Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

NCT03719131 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Melanoma, Stage III
Cutaneous Melanoma, Stage IV
Stage III Melanoma
Stage IIIA Skin Melanoma
Stage IIIB Skin Melanoma
Stage IIIC Skin Melanoma
Stage IV Skin Melanoma
Unresectable Melanoma

Interventions

DRUG: Nivolumab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Ipilimumab

Sponsor

Emory University

Collaborators

[object Object]